Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone

NCT02733679 is registered in ClinicalTrials.gov with NHS Tayside as lead sponsor.

NCT NCT02733679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02733679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Lead sponsor
NHS Tayside
Phase
Phase 4
Overall status
Completed
Start date
September 29, 2016
Completion date
August 30, 2017
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia-telangiectasia